Feasibility Usability & Acceptability Study: Symptom Reporting by Children Adolescents & Young Adults w/Cancer

Description

The purpose of this project is to pilot test an electronically delivered symptom assessment tool Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (Ped-PRO-CTCAE), completed by children/adolescents and young adults (AYAs) and caregivers and shared with their clinicians during an outpatient clinic visit, in preparation for a future test of intervention efficacy.

Conditions

Adolescent Behavior, Pediatric Cancer, Oncology

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this project is to pilot test an electronically delivered symptom assessment tool Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (Ped-PRO-CTCAE), completed by children/adolescents and young adults (AYAs) and caregivers and shared with their clinicians during an outpatient clinic visit, in preparation for a future test of intervention efficacy.

Symptom Reporting by Children, Adolescents and Young Adults With Cancer and Their Caregivers During a Clinic Visit: A Feasibility, Usability and Acceptability Study

Feasibility Usability & Acceptability Study: Symptom Reporting by Children Adolescents & Young Adults w/Cancer

Condition
Adolescent Behavior
Intervention / Treatment

-

Contacts and Locations

Palo Alto

Stanford University, Palo Alto, California, United States, 94304

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. First diagnosis of cancer
  • 2. Receiving cancer therapy: surgery, myelosuppressive chemotherapy and/or radiation
  • 3. 7-21 years of age
  • 4. Completed at least 1 month of cancer chemotherapy treatment and are within 7-28 days of starting a treatment cycle or during ongoing therapy, followed at least every month in clinic
  • 5. If surgery was part of treatment, the patient must be 3-6 weeks post surgery before participating in study
  • 6. Caregiver must be present and 18 years and older.
  • 7. Ability to understand and the willingness to personally sign the written IRB approved informed consent or assent document as appropriate.
  • 1. Child must be able to read or listen to and understand English and not have cognitive/memory impairments determined by the child's clinician
  • 2. Caregiver must be able to read and understand English.

Ages Eligible for Study

7 Years to 21 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Stanford University,

Kimberly Pyke-Grimm, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

2025-12